{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T06:04:59Z","timestamp":1769321099922,"version":"3.49.0"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T00:00:00Z","timestamp":1616976000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>To investigate European guideline treatment target achievement in cardiovascular risk factors, medication use, and lifestyle, after myocardial infarction (MI) or ischaemic stroke, in women and men living in Norway.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and results<\/jats:title>\n                  <jats:p>In the population-based Troms\u00f8 Study 2015\u201316 (attendance 65%), 904 participants had previous validated MI and\/or stroke. Cross-sectionally, we investigated target achievement for blood pressure (&amp;lt;140\/90\u2009mmHg, &amp;lt;130\/80\u2009mmHg if diabetes), LDL cholesterol (&amp;lt;1.8\u2009mmol\/L), HbA1c (&amp;lt;7.0% if diabetes), overweight (body mass index (BMI) &amp;lt;25\u2009kg\/m2, waist circumference women &amp;lt;80\u2009cm, men &amp;lt;94\u2009cm), smoking (non-smoking), physical activity (self-reported &amp;gt;sedentary, accelerometer-measured moderate-to-vigorous \u2265150\u2009min\/week), diet (intake of fruits \u2265200\u2009g\/day, vegetables \u2265200\u2009g\/day, fish \u2265200\u2009g\/week, saturated fat &amp;lt;10E%, fibre \u226530\u2009g\/day, alcohol women \u226410\u2009g\/day, men \u226420\u2009g\/day), and medication use (antihypertensives, lipid-lowering drugs, antithrombotics, and antidiabetics), using regression models. Proportion of target achievement was for blood pressure 55.2%, LDL cholesterol 9.0%, HbA1c 42.5%, BMI 21.1%, waist circumference 15.7%, non-smoking 86.7%, self-reported physical activity 79%, objectively measured physical activity 11.8%, intake of fruit 64.4%, vegetables 40.7%, fish 96.7%, saturated fat 24.3%, fibre 29.9%, and alcohol 78.5%, use of antidiabetics 83.6%, lipid-lowering drugs 81.0%, antihypertensives 75.9%, and antithrombotics 74.6%. Only 0.7% achieved all cardiovascular risk factor targets combined. Largely, there was little difference between the sexes, and in characteristics, medication use, and lifestyle among target achievers compared to non-achievers.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion\u2003<\/jats:title>\n                  <jats:p>Secondary prevention of cardiovascular disease was suboptimal. A negligible proportion achieved the treatment target for all risk factors. Improvement in follow-up care and treatment after MI and stroke is needed.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/eurjpc\/zwab050","type":"journal-article","created":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T20:11:08Z","timestamp":1615579868000},"page":"362-370","source":"Crossref","is-referenced-by-count":10,"title":["Treatment target achievement after myocardial infarction and ischaemic stroke: cardiovascular risk factors, medication use, and lifestyle: the Troms\u00f8 Study 2015\u201316"],"prefix":"10.1093","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0072-7421","authenticated-orcid":false,"given":"Laila A","family":"Hopstock","sequence":"first","affiliation":[{"name":"Department of Community Medicine, Faculty of Health Sciences, UiT The Arctic University of Norway, Hansine Hansens vei, 9037 Troms\u00f8, Norway"},{"name":"Pandemic Unit, Troms\u00f8 Municipality, Troms\u00f8, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7973-0342","authenticated-orcid":false,"given":"Bente","family":"Morseth","sequence":"additional","affiliation":[{"name":"School of Sport Sciences, Faculty of Health Sciences, UiT The Arctic University of Norway, Troms\u00f8, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Cook","sequence":"additional","affiliation":[{"name":"Faculty of Population Health, London School of Hygiene & Tropical Medicine, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7900-501X","authenticated-orcid":false,"given":"Anne Elise","family":"Eggen","sequence":"additional","affiliation":[{"name":"Department of Community Medicine, Faculty of Health Sciences, UiT The Arctic University of Norway, Hansine Hansens vei, 9037 Troms\u00f8, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0601-0344","authenticated-orcid":false,"given":"Sameline","family":"Grimsgaard","sequence":"additional","affiliation":[{"name":"Department of Community Medicine, Faculty of Health Sciences, UiT The Arctic University of Norway, Hansine Hansens vei, 9037 Troms\u00f8, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7111-6401","authenticated-orcid":false,"given":"Marie W","family":"Lundblad","sequence":"additional","affiliation":[{"name":"Department of Community Medicine, Faculty of Health Sciences, UiT The Arctic University of Norway, Hansine Hansens vei, 9037 Troms\u00f8, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8532-6573","authenticated-orcid":false,"given":"Maja-Lisa","family":"L\u00f8chen","sequence":"additional","affiliation":[{"name":"Department of Community Medicine, Faculty of Health Sciences, UiT The Arctic University of Norway, Hansine Hansens vei, 9037 Troms\u00f8, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8887-6100","authenticated-orcid":false,"given":"Ellisiv","family":"Mathiesen","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospital of North Norway, Troms\u00f8, Norway"},{"name":"Department of Clinical Medicine, UiT The Arctic University of Norway, Troms\u00f8, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amalie","family":"Nilsen","sequence":"additional","affiliation":[{"name":"Department of Community Medicine, Faculty of Health Sciences, UiT The Arctic University of Norway, Hansine Hansens vei, 9037 Troms\u00f8, Norway"},{"name":"Department of Medicine, Nordland Hospital, Bod\u00f8, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6391-231X","authenticated-orcid":false,"given":"Inger","family":"Nj\u00f8lstad","sequence":"additional","affiliation":[{"name":"Department of Community Medicine, Faculty of Health Sciences, UiT The Arctic University of Norway, Hansine Hansens vei, 9037 Troms\u00f8, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,3,29]]},"reference":[{"key":"2022031209200048100_zwab050-B1","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1161\/CIRCULATIONAHA.109.891523","article-title":"Association of diet, exercise, and smoking modification with risk of early cardiovascular events after acute coronary syndromes","volume":"121","author":"Chow","year":"2010","journal-title":"Circulation"},{"key":"2022031209200048100_zwab050-B2","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1093\/eurheartj\/ehs092","article-title":"European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)","volume":"33","author":"Perk","year":"2012","journal-title":"Eur Heart J"},{"key":"2022031209200048100_zwab050-B3","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","article-title":"2016 European Guidelines on cardiovascular disease prevention in clinical practice. The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)","volume":"37","author":"Piepoli","year":"2016","journal-title":"Eur Heart J"},{"key":"2022031209200048100_zwab050-B4","doi-asserted-by":"crossref","first-page":"633","DOI":"10.21037\/cdt.2017.04.06","article-title":"The EUROASPIRE surveys: lessons learned in cardiovascular disease prevention","volume":"7","author":"Kotseva","year":"2017","journal-title":"Cardiovasc Diagn Ther"},{"key":"2022031209200048100_zwab050-B5","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1177\/2047487318825350","article-title":"Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry","volume":"26","author":"Kotseva","year":"2019","journal-title":"Eur J Prev Cardiol"},{"key":"2022031209200048100_zwab050-B6","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1177\/2047487314547652","article-title":"Geographical variations in the prevalence and management of cardiovascular risk factors in outpatients with CAD: data from the contemporary CLARIFY registry","volume":"22","author":"Ferrari","year":"2015","journal-title":"Eur J Prev Cardiol"},{"key":"2022031209200048100_zwab050-B7","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1136\/hrt.2010.213710","article-title":"Effects of adherence to guidelines for the control of major cardiovascular risk factors on outcomes in the REduction of Atherothrombosis for Continued Health (REACH) Registry Europe","volume":"97","author":"Cacoub","year":"2011","journal-title":"Heart"},{"key":"2022031209200048100_zwab050-B8","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/j.amjcard.2014.03.006","article-title":"Trends in acute myocardial infarction event rates and risk of recurrences after an incident event in Norway 1994 to 2009","volume":"113","author":"Sulo","year":"2014","journal-title":"Am J Cardiol"},{"key":"2022031209200048100_zwab050-B9","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1186\/s12913-019-4538-7","article-title":"Fewer ischemic strokes, despite an ageing population: stroke models from observed incidence in Norway 2010\u20132015","volume":"19","author":"Rand","year":"2019","journal-title":"BMC Health Serv Res"},{"key":"2022031209200048100_zwab050-B10","first-page":"1841","article-title":"Hjerteinfarkt i Norge i 2013","volume":"134","author":"Jortveit","year":"2014","journal-title":"J nor Med Ass"},{"key":"2022031209200048100_zwab050-B11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/ane.13093","article-title":"Recurrent ischemic stroke: incidence, predictors, and impact on mortality","volume":"140","author":"Khanevski","year":"2019","journal-title":"Acta Neur Scand"},{"key":"2022031209200048100_zwab050-B12","article-title":"Pharmacy-dispensed drugs for secondary prevention after myocardial infarction","author":"Jortveit"},{"key":"2022031209200048100_zwab050-B13","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/joim.13161","article-title":"Vascular risk factor control and adherence to secondary preventive medication after ischaemic stroke","volume":"289","author":"Gynnild","year":"2020","journal-title":"J Int Med"},{"key":"2022031209200048100_zwab050-B14","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12872-016-0387-z","article-title":"Unfavourable risk factor control after coronary events in routine clinical practice","volume":"17","author":"Sverre","year":"2017","journal-title":"BMC Cardiovasc Dis"},{"key":"2022031209200048100_zwab050-B15","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/ije\/dyr049","article-title":"Cohort profile: the Troms\u00f8 Study","volume":"41","author":"Jacobsen","year":"2012","journal-title":"Int J Epidemiol"},{"key":"2022031209200048100_zwab050-B16","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1161\/CIRCULATIONAHA.115.016960","article-title":"Trends in modifiable risk factors are associated with declining incidence of hospitalized and non-hospitalized acute coronary heart disease in a population","volume":"133","author":"Mannsverk","year":"2016","journal-title":"Circulation"},{"key":"2022031209200048100_zwab050-B17","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/sms.12611","article-title":"The \u201cSaltin-Grimby Physical Activity Level Scale\u201d and its application to health research","volume":"25 Suppl 4","author":"Grimby","year":"2015","journal-title":"Scand J Med Sci Sports"},{"key":"2022031209200048100_zwab050-B18","doi-asserted-by":"crossref","first-page":"e000661","DOI":"10.1136\/bmjsem-2019-000661","article-title":"Criterion validity of two physical activity and one sedentary time questionnaire against accelerometry in a large cohort of adults and older adults","volume":"6","author":"Sagelv","year":"2020","journal-title":"BMJ Open Sport Exerc Med"},{"key":"2022031209200048100_zwab050-B19","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1475-2891-9-37","article-title":"Evaluation of energy and dietary intake estimates from a food frequency questionnaire using independent energy expenditure measurement and weighed food records","volume":"9","author":"Carlsen","year":"2010","journal-title":"Nutr J"},{"key":"2022031209200048100_zwab050-B20","year":"2015"},{"key":"2022031209200048100_zwab050-B21","doi-asserted-by":"crossref","first-page":"16","DOI":"10.29219\/fnr.v63.3616","article-title":"Energy and nutrient intakes in relation to National Nutrition Recommendations in a Norwegian population-based sample: the Troms\u00f8 Study 2015","volume":"63","author":"Lundblad","year":"2019","journal-title":"Food Nutr Res"},{"key":"2022031209200048100_zwab050-B22","year":"2016"},{"key":"2022031209200048100_zwab050-B23","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12872-019-1062-y","article-title":"Unsatisfactory risk factor control and high rate of new cardiovascular events in patients with myocardial infarction and prior coronary artery disease","volume":"19","author":"Jortveit","year":"2019","journal-title":"BMC Cardiovasc Dis"},{"key":"2022031209200048100_zwab050-B24","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"key":"2022031209200048100_zwab050-B25","doi-asserted-by":"crossref","first-page":"e000746","DOI":"10.1136\/openhrt-2017-000746","article-title":"Blood pressure target achievement and antihypertensive medication use in women and men after first-ever myocardial infarction: the Troms\u00f8 Study 1994\u20132016","volume":"5","author":"Hopstock","year":"2018","journal-title":"Open Heart"},{"key":"2022031209200048100_zwab050-B26","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1177\/1474515118762541","article-title":"Secondary prevention care and effect: total and low-density lipoprotein cholesterol levels and lipid-lowering drug use in women and men after incident myocardial infarction\u2014The Troms\u00f8 Study 1994\u20132016","volume":"17","author":"Hopstock","year":"2018","journal-title":"Eur J Cardiovasc Nurs"},{"key":"2022031209200048100_zwab050-B27","doi-asserted-by":"publisher","author":"Langholz","year":"2020","DOI":"10.1101\/2020.10.30.20222117"},{"key":"2022031209200048100_zwab050-B28","year":"2021"},{"key":"2022031209200048100_zwab050-B29","doi-asserted-by":"crossref","first-page":"e000997","DOI":"10.1136\/openhrt-2018-000997","article-title":"Adherence to coronary artery disease secondary prevention medicines: exploring modifiable barriers","volume":"6","author":"Khatib","year":"2019","journal-title":"Open Heart"},{"key":"2022031209200048100_zwab050-B30","doi-asserted-by":"crossref","first-page":"e568","DOI":"10.3399\/bjgp16X685609","article-title":"Barriers to medication adherence for the secondary prevention of stroke: a qualitative interview study in primary care","volume":"66","author":"Jamison","year":"2016","journal-title":"Brit J Gen Pract"},{"key":"2022031209200048100_zwab050-B31","doi-asserted-by":"crossref","first-page":"12028","DOI":"10.1038\/s41598-020-68915-1","article-title":"Medication adherence and its determinants in patients after myocardial infarction","volume":"10","author":"Pietrzykowski","year":"2020","journal-title":"Sci Rep"},{"key":"2022031209200048100_zwab050-B32","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1097\/HJH.0000000000001720","article-title":"Blood pressure-lowering drugs and secondary prevention of cardiovascular disease: systematic review and meta-analysis","volume":"36","author":"Xie","year":"2018","journal-title":"J Hypertens"},{"key":"2022031209200048100_zwab050-B33","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/eurheartj\/ehx566","article-title":"Effect of statins and non-statin LDL-lowering medications on cardiovascular outcomes in secondary prevention: a meta-analysis of randomized trials","volume":"39","author":"Koskinas","year":"2018","journal-title":"Eur Heart J"},{"key":"2022031209200048100_zwab050-B34","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1177\/2047487319830806","article-title":"Secular and longitudinal trends in cardiovascular risk in a general population using a national risk model: the Troms\u00f8 study","volume":"26","author":"Nilsen","year":"2019","journal-title":"Eur J Prev Cardiol"},{"key":"2022031209200048100_zwab050-B35","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12872-020-01368-6","article-title":"Preventable clinical and psychosocial factors predicted two out of three recurrent cardiovascular events in a coronary population","volume":"20","author":"Sverre","year":"2020","journal-title":"BMC Cardiovasc Dis"},{"key":"2022031209200048100_zwab050-B36","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1177\/2047487317703828","article-title":"Lifestyle modification in secondary prevention","volume":"24","author":"Piepoli","year":"2017","journal-title":"Eur J Prev Cardiol"},{"key":"2022031209200048100_zwab050-B37","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1177\/1474515119877999","article-title":"Secondary prevention and cardiovascular care across Europe: a survey of European Society of Cardiology members\u2019 views","volume":"19","author":"Fitzsimons","year":"2020","journal-title":"Eur J Cardiovasc Nurs"},{"key":"2022031209200048100_zwab050-B38","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1136\/heartjnl-2017-311429","article-title":"Sex differences in risk factor management of coronary heart disease across three regions","volume":"103","author":"Zhao","year":"2017","journal-title":"Heart"},{"key":"2022031209200048100_zwab050-B39","doi-asserted-by":"crossref","first-page":"zwaa144","DOI":"10.1093\/eurjpc\/zwaa144","article-title":"Gender gap in risk factor control of coronary patients far from closing: results from the European Society of Cardiology EUROASPIRE V registry","author":"Vynckier","year":"2020","journal-title":"Eur J Prev Cardiol"},{"key":"2022031209200048100_zwab050-B40","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/ije\/dys095","article-title":"Cohort Profile: the HUNT Study, Norway","volume":"42","author":"Krokstad","year":"2013","journal-title":"Int J Epidemiol"}],"container-title":["European Journal of Preventive Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurjpc\/article-pdf\/29\/2\/362\/42855045\/zwab050.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjpc\/article-pdf\/29\/2\/362\/42855045\/zwab050.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T09:20:22Z","timestamp":1647076822000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjpc\/article\/29\/2\/362\/6199131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,29]]},"references-count":40,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,3,29]]},"published-print":{"date-parts":[[2022,3,11]]}},"URL":"https:\/\/doi.org\/10.1093\/eurjpc\/zwab050","relation":{},"ISSN":["2047-4873","2047-4881"],"issn-type":[{"value":"2047-4873","type":"print"},{"value":"2047-4881","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,1,1]]},"published":{"date-parts":[[2021,3,29]]}}}